Lung Adenocarcinoma Clinical Trials in Shanghai, Shanghai Municipality
6 recruitingShanghai, Shanghai Municipality, China
Showing 1–6 of 6 trials
Recruiting
Not Applicable
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China690 enrolled14 locationsNCT04937283
Recruiting
Lymph Node Pathologic Grading Strategy
Lung Adenocarcinoma
Fudan University2,998 enrolled1 locationNCT06745830
Recruiting
Phase 3
Segmentectomy for Solid-dominant Lung Cancer
Lung AdenocarcinomaSegmentectomy
Fudan University277 enrolled1 locationNCT06634966
Recruiting
Phase 3
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
Lung AdenocarcinomaSegmentectomy
Fudan University307 enrolled1 locationNCT05717803
Recruiting
Phase 3
Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
Lung AdenocarcinomaFrozen SectionSublobar Resection
Fudan University390 enrolled1 locationNCT06031181
Recruiting
Phase 2
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
Lung Adenocarcinoma Stage IIILung Adenocarcinoma Stage IVEGFR Gene Mutation
Shanghai Pulmonary Hospital, Shanghai, China96 enrolled1 locationNCT05503667